Shares of Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.18 and traded as low as $1.9404. Organicell Regenerative Medicine shares last traded at $1.98, with a volume of 4,648 shares trading hands.
Organicell Regenerative Medicine Stock Performance
The stock has a 50-day moving average price of $1.99 and a two-hundred day moving average price of $2.18.
About Organicell Regenerative Medicine
Organicell Regenerative Medicine, Inc is a clinical‐stage biotechnology company dedicated to the development and commercialization of cell and exosome‐based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal‐like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.
The company’s pipeline is anchored by exosome‐centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.
Featured Articles
- Five stocks we like better than Organicell Regenerative Medicine
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
